Vanguard Group’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $144M | Buy |
|
|||||
|
2025
Q1 | $97.1M | Buy |
|
|||||
|
2024
Q4 | $157M | Sell |
|
|||||
|
2024
Q3 | $248M | Buy |
|
|||||
|
2024
Q2 | $198M | Buy |
|
|||||
|
2024
Q1 | $342M | Buy |
|
|||||
|
2023
Q4 | $504M | Buy |
|
|||||
|
2023
Q3 | $367M | Buy |
|
|||||
|
2023
Q2 | $477M | Sell |
|
|||||
|
2023
Q1 | $490M | Buy |
|
|||||
|
2022
Q4 | $307M | Buy |
|
|||||
|
2022
Q3 | $236M | Buy |
|
|||||
|
2022
Q2 | $354M | Buy |
|
|||||
|
2022
Q1 | $588M | Buy |
|
|||||
|
2021
Q4 | $1.13B | Sell |
|
|||||
|
2021
Q3 | $1.11B | Buy |
|
|||||
|
2021
Q2 | $1.39B | Buy |
|
|||||
|
2021
Q1 | $1.18B | Buy |
|
|||||
|
2020
Q4 | $876M | Buy |
|
|||||
|
2020
Q3 | $742M | Buy |
|
|||||
|
2020
Q2 | $353M | Buy |
|
|||||
|
2020
Q1 | $67.6M | Buy |
|
|||||
|
2019
Q4 | $79.5M | Buy |
|
|||||
|
2019
Q3 | $36.7M | Buy |
|